Calnexin Impairs the Antitumor Immunity of CD4+ and CD8+ T Cells
Yi‐Chen Chen(National Cheng Kung University), Zhi Wang(Tongji Hospital), Jun Cui(Xinjiang Medical University), Bin Cheng(Columbia University Irving Medical Center), Xiangqi Liu(Hebei University of Economics and Business), Lieping Chen(Yale Cancer Center), Xinye Li(Guangdong Province Stomatological Hospital), Juan Xia(University of Electronic Science and Technology of China), Jingjing Song(Qingdao University), Xianyue Ren(Sun Yat-sen University), Liqun Luo(Sun Yat-sen University), Juan Fang(Guangdong Province Stomatological Hospital), Xi Wang(Guangdong Province Stomatological Hospital), Da Ma(Sun Yat-sen University), Qiusheng Li(Guangdong Province Stomatological Hospital), Gucheng Zeng(Sun Yat-sen University), Shuqiong Wen(Guangdong Province Stomatological Hospital), Qunxing Li(Guangdong Province Stomatological Hospital)
Cited by 29
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5k
Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
|Journal of Clinical Investigation|2015|1.4k
Programmed death ligand-1 expression in non-small cell lung cancer
|Laboratory Investigation|2013|753
B7-H4, a Molecule of the B7 Family, Negatively Regulates T Cell Immunity
|Immunity|2003|694